AI
DXCM icon

AXS Investments’s DexCom DXCM Stock Holding History

AXS Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.5K Sell
676
-171
-20% -$11.4K 0.01% 167
2026
Q1 		$53.2K Sell
847
-159
-16% -$11.1K 0.02% 154
2025
Q4 		$66.8K Sell
1,006
-156
-13% -$10.1K 0.02% 161
2025
Q3 		$78.2K Buy
+1,162
New +$92K 0.02% 158
2024
Q1 		– Sell
-1,120
Closed -$139K – 336
2023
Q4 		$139K Sell
1,120
-128
-10% -$13.1K 0.03% 316
2023
Q3 		$116K Sell
1,248
-133
-10% -$15K 0.03% 295
2023
Q2 		$177K Buy
1,381
+26
+2% +$3.15K 0.05% 268
2023
Q1 		$157K Sell
1,355
-163
-11% -$18.2K 0.05% 228
2022
Q4 		$172K Buy
+1,518
New +$167K 0.06% 201
2022
Q2 		– Sell
-2,184
Closed -$279K – 210
2022
Q1 		$279K Sell
2,184
-820
-27% -$89.7K 0.11% 118
2021
Q4 		$403K Buy
+3,004
New +$432K 0.1% 123
2021
Q3 		– Sell
-5,144
Closed -$549K – 138
2021
Q2 		$549K Buy
5,144
+888
+21% +$85.3K 0.17% 111
2021
Q1 		$382K Buy
+4,256
New +$400K 0.14% 122

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AXS Investments's DXCM Position: Q2 2026 in Review

AXS Investments reduced its DexCom (DXCM) stake by 20% in Q2 2026, selling an estimated $11.4K and leaving 676 shares worth $45.5K. The position accounts for 0.01% of the portfolio, ranked #167.

AXS Investments first reported a position in DXCM in Q1 2021 and has held it in 13 quarters since. The position peaked at $549K in Q2 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • AXS Investments held 676 shares of DexCom worth $45.5K as of Q2 2026.
  • AXS Investments sold 171 DexCom shares in Q2 2026, an estimated $11.4K.
  • DexCom made up 0.01% of AXS Investments's portfolio in Q2 2026, its #167 holding.
  • AXS Investments first reported a position in DexCom in Q1 2021 and has held it in 13 quarters since.
  • AXS Investments's DexCom position peaked at $549K in Q2 2021.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.